*Image generated by ChatGPT
According to a report from Futurism, a team of researchers has conducted gene editing on human zygotes, the earliest single-cell stage of embryos, reigniting intense debate over the technology’s future applications.
The experiment, detailed in a yet-to-be-peer-reviewed paper, was led by Columbia University geneticist Dieter Egli. Using a precise technique known as base editing—which targets a single DNA base rather than cutting larger segments as with traditional CRISPR—the team modified two specific genomic sites involved in cholesterol metabolism and hemoglobin production.
These sites were chosen because they are well-studied in other gene-editing contexts, not for immediate therapeutic promise in embryos.
The researchers emphasized that their work was not aimed at creating new medical treatments but at proving base editing could safely modify embryonic DNA without the risks of mosaicism or other damage seen in prior CRISPR attempts. The edited embryos were not implanted or carried to term.
However, the study has sparked significant concern among experts. Alexis Komor, a pioneering genome-editing researcher who helped develop CRISPR base editing, warned that the work could pave the way for more controversial applications. “The cat’s out of the bag,” she told Scientific American, noting the absence of strict regulatory oversight in the US and suggesting the research “kind of opens the floodgates.”
Komor further described the study as “a gateway to embryo editing to do enhancements,” echoing broader fears that such advancements could shift from disease prevention toward trait selection.
The research received support from Nucleus Genomics, a company involved in screening IVF embryos that has faced prior scrutiny. While some scientists remain optimistic about eventual therapeutic potential, others are sharply critical. University of California, Berkeley geneticist Fyodor Urnov stated, “What they are really doing is providing the ‘baby improvers’ with a how-to manual for forays beyond the ethical pale.”
Bioethicist Ana Iltis of Wake Forest University highlighted potential risks, noting, “It is possible that some of the potentially harmful effects would not be evident until after birth.”
Coauthor Nathan Treff of Nucleus Genomics acknowledged the challenges ahead, saying, “There’s still work to do before getting to that point, but this research gets us closer.”
End Time Headlines is a ministry founded, owned, and operated by Ricky Scaparo, established in 2010 to equip believers and inform discerning individuals about the “Signs and Seasons” of the times in which we live. Ricky authors original articles and curates news from mainstream sources, carefully selecting topics, verifying information, and utilizing artificial intelligence tools to ensure content is both timely and accurate. Every piece is personally reviewed and edited by Ricky to align with the ministry’s mission of providing a prophetic perspective on current events.